REG - Intuitive Invests.Gp - Update on Sanondaf

Intuitive InvestmentsAnnouncement

26/05/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220526:nRSZ8488Ma&default-theme=true

RNS Number : 8488M  Intuitive Investments Group plc  26 May 2022

 

26 May 2022

Intuitive Investments Group plc

Update on Sanondaf

Sanondaf awards new regional franchise and key appointments

Intuitive Investments Group plc, (AIM: IIG) ("IIG") announces the following
update in respect of its largest single investment, Sanondaf.

 

Sanondaf awards new regional franchise

Sanondaf, a specialist disinfection and hygiene services business, has awarded
a regional franchise in Kent, which covers the Discovery Science Park in
Sandwich. The franchise will be headed by John Wamsley who runs a successful
equipment supply and reconditioning business. He has an extensive knowledge
of, and excellent relationships in, the life sciences sector.

This new regional franchise increases the number of regional franchises to 26,
giving excellent and growing coverage throughout the United Kingdom. The award
is in line with Sanondaf's targeted growth strategy in the life science
sector. Sanondaf is a trusted partner of companies ranging from life science
start-ups to multi-nationals. Customers include the NHS, research laboratories
and pharmaceutical manufacturers.

Strengthening of the Sanondaf Team

Furthermore, Sanondaf announces three appointments.

Tom Hyland, Operations Director, has held senior positions in global life
sciences companies including Johnson & Johnson Medical, Microsulis, Life
Technologies and Alere Technologies. Tom started his career as a chemical
engineer, has a chemistry degree and holds an MBA. Tom combines excellent
technical engineering ability with exceptional managerial skills and will be
responsible for operations and product development.

 

Collette McMorrow, Business Manager, has proven expertise in marketing,
project management, business development and event management. Collette has
held senior roles in leading companies such as Bayer and has a proven track
record in digital system design, leadership, and performance management.

Helen McPike, Product Specialist, is a biosecurity specialist who has 20
years' experience in healthcare and has spent the last eight years working in
the infection prevention and control sector. Helen has held senior sales roles
and worked for the NHS, Byotrol and Fresnius and has first class honours
science degree in Health Science.

For further information, please contact:

 

 Intuitive Investments Group plc                       www.iigplc.com (http://www.iigplc.com/)
 Julian Baines, Non-Executive Chairman                 Via Walbrook PR

 Robert Naylor, CEO

 SP Angel Corporate Finance LLP - Nominated Adviser    +44 (0) 20 3470 0470
 Jeff Keating / David Hignell / Kasia Brzozowska

 Turner Pope Investments (TPI) Ltd - Broker            +44 (0) 20 3657 0050
 Andrew Thacker / James Pope

 Walbrook PR Limited - Media & Investor Relations      +44 (0)20 7933 8780 or intuitive@walbrookpr.com
                                                       (mailto:intuitive@walbrookpr.com)
 Paul McManus/ Sam Allen                               +44 (0) 7980 541 893 / +44 (0) 7502 558 258

 

About Sanondaf

Sanondaf provides specialist disinfection and hygiene services, primarily
through its core technology of spraying and fogging.  Sanondaf's
decontamination service is based around a hydrogen peroxide formula, which is
administered as a dry vapour disinfection treatment which can be used on all
electrical and electronic devices and all hard and soft furnishings safely,
without causing damage or leaving any unsightly residue on the surfaces
treated. Treatments are non-corrosive, contain no toxic ingredients and
Sanondaf's application methods ensure they are not harmful to people, animals
or the environment. It is safe for use in all settings, including operating
theatres, critical care units, and is CASA (Civil Aviation Safety Authority)
approved. Sanondaf's disinfection formula has proven efficacy against
pathogens, including, viruses such as Covid-19 and Monkeypox, mould, bacteria
and fungi.

 

About Intuitive Investments Group plc

The Company is an investment company seeking to provide investors with
exposure to a portfolio concentrating on fast growing and/or high potential
Life Sciences businesses operating predominantly in the UK, continental Europe
and the US, utilising the Board's experience and in particular that of the
chairman of the Investment Committee, David Evans, to seek to generate capital
growth over the long term for shareholders.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPURCAUPPPGA